| | |

Keto Diet for Mesothelioma Not Advised Despite New Research

keto diet for mesothelioma

New research suggests a diet low in carbs and sugar may slow the growth of certain kinds of cancer cells. The news may have mesothelioma patients wondering about the value of the keto diet for mesothelioma, too. 

The new study appears in the most recent issue of the journal Cell Reports. Researchers fed a restrictive ketogenic diet to mice with a certain kind of lung cancer. They also gave them a drug to keep the kidneys from absorbing extra glucose.

The trial was not focused specifically on the keto diet for mesothelioma. But the findings do show that sugar and certain cancers do not mix. 

What is the Ketogenic Diet?

The ketogenic – or “keto” – diet is very low in sugar and carbs and high in fat. It is similar to the Atkins diet and other low-carb eating plans but it is even more restrictive. 

The lower carb level throws the body into a metabolic state called ketosis. While some people use the keto diet to lose weight, some studies have suggested that it may also help fight diabetes and Alzheimer’s disease. 

The new research is based on the idea that many types of cancer, including malignant mesothelioma, rely on sugar for energy. The keto diet keeps sugar levels very low. 

Even so, cancer experts do not routinely recommend the keto diet for mesothelioma or any other type of cancer. 

Results of the Keto Diet Study

There is no data on the keto diet for mesothelioma. In fact, the weight loss and nutritional imbalances that it can cause may be dangerous for patients going through mesothelioma treatment.

But the new multinational study shows that squamous cell carcinoma is highly susceptible to this eating plan. 

“Both the ketogenic diet and the pharmacological restriction of blood glucose by themselves inhibited the further growth of squamous cell carcinoma tumors in mice with lung cancer,” says study author Dr. Jung-Whan Kim. 

Neither the keto diet nor the blood sugar drug shrunk the mouse tumors. They only kept them from growing bigger. 

Testing the Connection Between Blood Sugar and Cancer

To see what kind of impact blood sugar levels had on human cancers, researchers tested the blood of 192 patients. They found that squamous cell carcinoma patients with the lowest blood sugar levels had the longest cancer survival.

The results are potentially exciting for patients with that type of cancer. But they do not suggest that the keto diet for mesothelioma or other types of cancer is a good idea. There was no sugar-linked survival difference in patients with non-squamous cell lung cancer. 

“Our results suggest that this approach is cancer-cell-type specific. We cannot generalize to all types of cancer,” says Dr. Kim.

While the keto diet for mesothelioma may not be advisable, the study contains another lesson. Dr. Kim says it may open the door to new ways to fight cancer by working with the body’s own systems. 

“Maybe we can manipulate our own biological system a little bit or activate something we already have in place in order to more effectively combat cancer,” he says. 

The world’s longest-living mesothelioma patient, Paul Kraus, is an excellent example of how diet may impact mesothelioma survival. To read about his eating and lifestyle plan for survival, read his book, Surviving Mesothelioma and Other Cancers

Every mesothelioma patient is different. Patients should consult their doctor before making any changes to their diet, especially during mesothelioma treatment.

Sources:

“Biologists’ Preclinical Work Suggests Keto Diet Has Anti-Cancer Effect”, August 15, 2019, University of Texas at Dallas news release, https://www.utdallas.edu/news/research/preclinical-research-suggests-keto-diet-has-anti-cancer-effect/?WT.mc_id=NewsHomePage

Hsieh, MH, et al, “p63 and SOX2 Dictate Glucose Reliance and Metabolic Vulnerabilities in Squamous Cell Carcinomas”, August 13, 2019, Cell Reports, https://www.cell.com/cell-reports/fulltext/S2211-1247(19)30924-6?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2211124719309246%3Fshowall%3Dtrue

Similar Posts

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • |

    Chemical in Wine May Improve Mesothelioma Treatment

    There’s new evidence that a compound found in red wine may help improve the effectiveness of chemotherapy treatment for malignant pleural mesothelioma. Last year, a team of Korean researchers released the world’s first study on the mesothelioma-fighting power of resveratrol, a natural phenol derived from the skin of red grapes and found in red wine and grape juice. Now, the same team says resveratrol also appears to enhance the chemosensitivity of malignant mesothelioma cells. Study author Yoon-Jin Lee and colleagues discovered  a synergistic cancer-fighting effect in mesothelioma cells treated with both resveratrol and clofarabine, a prescription drug often used to treat acute lymphoblastic leukemia. Together, resveratrol and clofarabine “induced a strong cytotoxic effect” by influencing levels of the tumor suppressor,…

  • | |

    Micro-RNAs May Offer New Way to Fight Mesothelioma

    Scientists at one of the world’s top mesothelioma research centers, the Asbestos Diseases Research institute in Sydney, Australia, say that restoring the expression of certain micro RNAs in the cells of mesothelioma patients may offer a new way to fight the disease. A microRNA is a small RNA molecule which is involved in the regulation of gene expression. According to a new report in the Annals of Oncology, the Australian scientists found reduced expression of the micro RNA-15 family (miR-15/16) in the cells of mice with mesothelioma. “When malignant pleural mesothelioma cell lines were compared with the normal mesothelial cell line MeT-5A, the downregulation of miR-15/16 was 2- to 10-fold,” they report. This finding is consistent with previous cancer research…

  • | |

    Treatment Uses Herpes Virus to Shrink Mesothelioma Tumors

    Researchers at a hospital in Sheffield, England are testing a potential new mesothelioma treatment based on the same virus that causes herpes. The small-scale trial is the first in the world to test the modified herpes simplex virus, HSV1716, in human mesothelioma patients. HSV1716 has been genetically engineered to infect and kill cancer cells without harming healthy cells. In laboratory studies on mesothelioma and some other cancers, it has been shown to be effective at shrinking tumors while causing limited toxicity. Just as significantly, HSV1716 increased survival rates among mice with various human cancers. The Phase I/II trial at Sheffield Experimental Cancer Medicine Centre is the next stage in development of HSV1716 as a viable mesothelioma treatment. The goal of…

  • | |

    New Mesothelioma Drug Kills Cancer Stem Cells

    Citing “significant enthusiasm within the mesothelioma community”, the manufacturers of a promising new mesothelioma drug say they have begun a major test of the drug in patients. Massachusetts-based Verastem, Inc. focuses on drugs that fight cancer by attacking the stem cells that give rise to them. Earlier this summer, the FDA granted orphan drug status to their stem cell inhibitor, defactinib, for the treatment of mesothelioma. The designation, which is reserved for drugs that fight the rarest of diseases, helps pave the way for testing and faster approval, depending on the results of clinical trials. “Development of a drug that preferentially kills cancer stem cells is a promising approach, as many standard-of-care treatments have been shown to either have no…

  • | |

    Mesothelioma Study Finds New Treatment Target

    Immunotherapy, which involves reprogramming T-cells to find and attack cancer cells, is one of the fastest-growing areas of cancer research. One of the biggest challenges of immunotherapy is how to harness the power of T-cells against cancer without also turning them against healthy cells. A new study conducted in Switzerland and published in the Journal of Translational Medicine addressed the problem by reprogramming T-cells to recognize and attack mesothelioma cells that express a specific protein. Fibroblast Activation Protein (FAP) is expressed on the surface of tumor-associated fibroblast cells which are found in the connective tissue of mesothelioma tumors. FAP is also found in mesothelioma cells and may play a role in the start of cancer, as well as the growth…